- Amjevita, a Biosimilar to Humira, Now Available
- Open-Label Trial Designs Do Not Seem to Influence Patient-Reported Outcomes
- Adults With Chronic Pain Replace Opioids With Medical Cannabis for Pain Relief
- Immunotherapy Matches Cyclosporin A in Resolving Allergic Conjunctivitis Signs
- Canadian Province Decriminalizes Small Amounts of Hard Drugs
- Childhood Maltreatment Is Partial Causal Factor for Later Mental Health Problems
- Nearly Half of People With Dementia Experience a Fall Annually
- Biden to Lift COVID-19 Emergencies in May
- Skin Barrier Function and Verbal Memory in Older Adults
- Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders
- Rate of Young Children Exposed to Edible Cannabis Grows Alarmingly
- Depressive Symptoms Reduced With Psilocybin Single Moderate Dose
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
Graded Sensorimotor Retraining Modestly Improves Chronic Back Pain
2023 Standards of Care in Diabetes Released
Patients With Bipolar Disorder May Have Unique Age-Related Cognitive Decline
Renal Function Impacts Efficacy of Dual-Antiplatelet Therapy After Minor Stroke
Perceived Burdens Predict Patients’ Withdrawal From Cancer Trials
